I
Instituto De Investigaciones Clinicas Zarate | Zarate, Argentina
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PF-07321332
Ritonavir
Bococizumab
Olpasiran
Trastuzumab
Evolocumab
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 9 total trials
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...
Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Olpasiran
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems